617.7000 -3.10 (-0.50%)
NSE Jun 27, 2025 15:31 PM
Volume: 228.8K
 

Axis Direct
We expect Gross Margins to be impacted due to an increase in revenue share from non-regulated markets and an increase in raw material prices going onwards. Hence, we recommend a HOLD rating on the stock with a target price of INR 1,670 (PE 20x for FY23EPS).
Solara Active Pharma Sciences Ltd. has gained 16.56% in the last 1 Week
More from Solara Active Pharma Sciences Ltd.
Recommended